Zobrazeno 1 - 10
of 215
pro vyhledávání: '"Tien Hsing Chen"'
Autor:
Dong‐Yi Chen, Chun‐Chi Chen, Cheng‐Hung Lee, Chi‐Nan Tseng, Shao‐Wei Chen, Shang‐Hung Chang, Tien‐Hsing Chen, Pao‐Hsien Chu, I‐Chang Hsieh, Ming‐Shien Wen, Ming‐Lung Tsai, Ming‐Jer Hsieh
Publikováno v:
ESC Heart Failure, Vol 11, Iss 4, Pp 2259-2271 (2024)
Abstract Aims The PIONEER‐HF and PARAGLIDE‐HF trials aimed to determine the efficacy and safety of the in‐hospital initiation of sacubitril/valsartan in patients hospitalized for AHF. However, whether the inclusion and exclusion criteria of the
Externí odkaz:
https://doaj.org/article/3df3cbf84add40b389c311b6a71fb639
Autor:
Ming-Shyan Lin, Po-Chang Wang, Meng-Hung Lin, Ting-Yu Kuo, Yu-Sheng Lin, Tien-Hsing Chen, Ming-Horng Tsai, Yao-Hsu Yang, Chun-Liang Lin, Chang-Min Chung, Pao-Hsien Chu
Publikováno v:
BMC Cardiovascular Disorders, Vol 23, Iss 1, Pp 1-11 (2023)
Abstract Background Little research has been done on ischemic outcomes related to left ventricular ejection fraction (EF) in acute decompensated heart failure (ADHF). Methods A retrospective cohort study was conducted between 2001 and 2021 using the
Externí odkaz:
https://doaj.org/article/8fd3039c0c4b45d5a4b7ce916e5da17a
Autor:
Ming-Lung Tsai, Yuan Lin, Ming-Shyan Lin, Tzu-Hsien Tsai, Ning-I Yang, Chao-Yung Wang, I-Chang Hsieh, Ming-Jui Hung, Tien-Hsing Chen
Publikováno v:
Diabetology & Metabolic Syndrome, Vol 15, Iss 1, Pp 1-12 (2023)
Abstract Background and aims Clinical comparisons of angiotensin receptor–neprilysin inhibitors (ARNI) and sodium–glucose cotransporter 2 inhibitors (SGLT2i) treatment in patients with HFrEF and T2DM are limited. This study evaluated the clinical
Externí odkaz:
https://doaj.org/article/50681a385e1f4a9a89c36429eaa0c8c7
Autor:
Yuan Lin, Te-Hsiung Wang, Ming-Lung Tsai, Victor Chien-Chia Wu, Chin-Ju Tseng, Ming-Shyan Lin, Yan-Rong Li, Chih-Hsiang Chang, Tien-Shin Chou, Tzu-Hsien Tsai, Ning-I Yang, Ming-Jui Hung, Tien-Hsing Chen
Publikováno v:
Cardiovascular Diabetology, Vol 22, Iss 1, Pp 1-11 (2023)
Abstract Background To determine whether glucagon-like peptide 1 receptor agonists (GLP-1RAs) have cardiovascular and renal protective effects in patients with advanced diabetic kidney disease (DKD) with an estimated glomerular filtration rate (eGFR)
Externí odkaz:
https://doaj.org/article/28ce83582cd14ad9a80819fa3b02b39a
Publikováno v:
Medicina, Vol 60, Iss 3, p 357 (2024)
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have been used to reduce glucose levels in patients with type 2 diabetes mellitus since 2005. This meta-analysis discusses the mechanisms and potential benefits of several GLP-1 RAs. In particular
Externí odkaz:
https://doaj.org/article/743439a64b68458e861046394e95a607
Autor:
Hsuan-Ching Lin, Ming-Jui Hung, Chao-Hung Wang, Tien-Hsing Chen, Wei-Siang Chen, Chi-Wen Cheng
Publikováno v:
Medicina, Vol 59, Iss 8, p 1499 (2023)
Background and Objectives: The demand for permanent pacemaker (PPM) implantation for extremely old patients is increasing. Prior to implanting PPMs, life expectancy evaluation is essential but difficult. We aimed to develop and validate a scoring sys
Externí odkaz:
https://doaj.org/article/1464ee9ee7b14c20b45742e51f7df922
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
PurposeTo investigate the risk and protective factors of dry eye disease (DED) in patients with type II diabetes mellitus (DM).DesignA retrospective cohort study using Chang- Gung research database collecting data from 2005 to 2020.MethodsPatients wi
Externí odkaz:
https://doaj.org/article/06cf6a05e6e443af9554ff71bd879745
Autor:
Po-Chang Wang, Tien-Hsing Chen, Chang-Min Chung, Mei-Yen Chen, Jung-Jung Chang, Yu-Sheng Lin, Pao-Hsien Chu, Yun-Shing Peng, Ming-Shyan Lin
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Abstract Little is known about the association between deep vein thrombosis (DVT) and arterial complications in patients with type 2 diabetes (T2DM). The aim of this retrospective cohort study was to assess the influence of prior DVT on major adverse
Externí odkaz:
https://doaj.org/article/58c42ebd677b4dafaccf56a03803ca8c
Autor:
Yu-Cheng Kao, Tien-Hsing Chen, Chi-Hung Liu, Jawl-Shan Hwang, Ching-Chung Hsiao, Yu-Sheng Lin, Chun-Tai Mao, Ming-Jui Hung, Yan-Rong Li
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Abstract Atorvastatin 40 mg (ATOR 40) and ezetimibe 10 mg/simvastatin 20 mg (EZ-SIM 20) have similar reductions of low-density lipoprotein cholesterol (LDL-C) but cardiovascular (CV) outcomes between these two therapies are unclear. Our real-world co
Externí odkaz:
https://doaj.org/article/d4191a5e624647d6b01ef66502373c4b
Autor:
Ming-Lung Tsai, Shu-I Lin, Yu-Cheng Kao, Hsuan-Ching Lin, Ming-Shyan Lin, Jian-Rong Peng, Chao-Yung Wang, Victor Chien-Chia Wu, Chi-Wen Cheng, Ying-Hsiang Lee, Ming-Jui Hung, Tien-Hsing Chen
Publikováno v:
Medicina, Vol 59, Iss 2, p 348 (2023)
Background and Objectives: An elevated heart rate is an independent risk factor for cardiovascular disease; however, the relationship between heart rate control and the long-term outcomes of patients with heart failure with reduced ejection fraction
Externí odkaz:
https://doaj.org/article/b901098c08154e499d7bbf57a3851753